Central and NO mediated mechanisms are involved in the inhibitory effects of CCK on the chicken cecorectal area.
In chickens CCK-8s induces defecation and causes an inhibition of rectal electrical activity (EA) and an increase in cecal motility. In contrast, CCK-4 inhibits the motility of both rectum and ceca. The cecorectal responses to CCK-8s and CCK-4, given intravenously (i.v.), were studied in conscious chickens prepared with electrodes for electromyography; the influence of atropine, phentolamine plus propranolol, hexamethonium and L-NAME on such responses was determined. Atropine and phentolamine plus propranolol did not cause any change in the response to CCK-8s or CCK-4 in the cecorectal area. Hexamethonium only induced a significant decrease in the number of defecations (ND) induced by CCK-8s. L-NAME slightly modified the decrease in rectal EA due to CCK-8s. The effects of intracerebroventricular (i.c.v.) administration of CCK-8s and CCK-4 were also studied. CCK-8s and CCK-4, given i.c.v., caused, in conscious chickens, a slight decrease in cecal EA, in the 15 minutes following administration. This effect was similar to that seen after i.v. administration of CCK-4. In conclusion, our results suggest that the inhibitory action of CCK on chicken rectum is mediated, at least in part, through nitric oxide release. In addition, nicotinic receptors mediate the increase in the ND caused by CCK-8s. Ganglionic, muscarinic, adrenergic and nitrergic blockade were not able to modify the excitatory cecal response to CCK-8s, which may indicate that the receptor mediating this effect is located on the cecal smooth muscle. Finally, the inhibitory action of i.v. CCK-4 on chicken cecum seems to be centrally mediated, as suggested by the fact that i.c.v. administration of either CCK-8s or CCK-4 induce a similar effect.
Rodríguez-Sinovas
A
A
Physiology Unit, Veterinary Faculty, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Fernández
E
E
Goñalons
E
E
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D002432:Cecum / Q000187:drug effects* / Q000502:physiology; D002645:Chickens; D003672:Defecation / Q000187:drug effects; D004576:Electromyography; D018738:Hexamethonium / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D019331:NG-Nitroarginine Methyl Ester; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012007:Rectum / Q000187:drug effects* / Q000502:physiology; D012844:Sincalide / Q000008:administration & dosage / Q000494:pharmacology*; D013758:Tetragastrin / Q000494:pharmacology*
D013758:Tetragastrin; D018738:Hexamethonium; D001285:Atropine; D001120:Arginine; D011433:Propranolol; D012844:Sincalide; D019331:NG-Nitroarginine Methyl Ester; D010646:Phentolamine